Responses
EULAR 2014: Scientific Abstracts
Poster Presentations. Rheumatoid arthritis - prognosis, predictors and outcome
THU0262 Comparing Abatacept to Adalimumab, Etanercept and Infliximab as First or Second Line Agents in Patients with Rheumatoid Arthritis. Experience from the Rhumadata® Clinical Database and Registry
Compose a Response to This Article
Other responses
No responses have been published for this article.